8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2009 / Prospective, matched controlled study
A 24-month prospective study evaluated 120 matched organ transplant recipients where 60 patients received free broad-spectrum sunscreen (SPF>50) for daily application alongside standard sun protection advice given to all participants. Over 24 months, 8 new invasive SCCs occurred in the control group versus 0 in the sunscreen group (P<0.01), and new AK counts differed significantly (-102 in sunscreen group vs. +82 in controls; P<0.01). BCC occurrences were 2 in the sunscreen group versus 9 in controls (not significant). Serum 25(OH)D levels were lower in the sunscreen group than controls (mean 53 ng mL(-1) vs. 60 ng mL(-1)).
Ulrich C, Jürgensen JS, Degen A, et al. Br J Dermatol, 2009. PMID 19775361
2009 / Randomized placebo-controlled trial
Patients with high-risk oral premalignant lesions received green tea extract (500, 750, or 1,000 mg/m2) or placebo three times daily for 12 weeks. Clinical response was 50% across extract groups (n = 28) versus 18.2% for placebo (n = 11; P = 0.09), but reached 58.8% in the two highest-dose groups combined (P = 0.03). Histologic improvement was not significantly different (P = 0.65), and while higher doses increased insomnia and nervousness, no grade 4 toxicities were seen.
Tsao AS, Liu D, Martin J, et al. Cancer Prev Res (Phila), 2009. PMID 19892663
2009 / Unblinded crossover trial
An unblinded crossover study evaluated the pharmacokinetics of a microdose of 14C-AFB(1) (30 ng) alone or co-administered with 150 mg of purified chlorophyll (Chla) or chlorophyllin (CHL) across three protocols repeated thrice in human volunteers. Fasted AFB(1) alone showed rapid uptake with plasma k(a) of 5.05 ± 1.10 h(-1), T(max) of 1.0 hour, and 95% complete urinary elimination by 24 hours. Co-treatment with Chla or CHL significantly impeded AFB(1) absorption and reduced Cmax and AUCs in plasma and urine in one or more subjects.
Jubert C, Mata J, Bench G, et al. Cancer Prev Res (Phila), 2009. PMID 19952359
2008 / Randomized controlled trial
Ninety-three early-stage prostate cancer patients were randomized to usual care or a very-low-fat vegan diet with soy supplementation and lifestyle changes for 1 year. The intervention group significantly increased protective factors, such as fiber (31 to 59 g/day) and lycopene (8,693 to 34,464 mcg/day). Pathogenic factors decreased, including saturated fat (20 to 5 g/day) and cholesterol (200 to 10 mg/day).
Dewell A, Weidner G, Sumner MD, et al. J Am Diet Assoc, 2008. PMID 18237581
2008 / Comparative crossover trial
Twelve healthy men aged 35-56 experienced matched 3-day/2-night trips to forest fields and to a city. The forest trip significantly increased NK activity, numbers of NK cells, and perforin-, granulysin-, and granzyme A/B-expressing cells, while significantly reducing urinary adrenaline; the elevated NK activity lasted over 7 days. In contrast, the city trip did not increase NK activity, NK cells, or anti-cancer proteins, nor did it lower urinary adrenaline. Phytoncides such as alpha-pinene and beta-pinene were detected in forest air but almost absent in city air.
Li Q, Morimoto K, Kobayashi M, et al. Int J Immunopathol Pharmacol, 2008. PMID 18336737
2008 / Before-and-after intervention study
Thirteen healthy female nurses participated in a 3-day/2-night forest bathing trip involving walking in forest fields. Blood and urine samples were collected before the trip, during the trip, and on days 7 and 30 post-trip. The trip significantly increased natural killer (NK) activity and numbers of NK cells, perforin, granulysin, and granzymes A/B-expressing cells, while significantly reducing the percentage of T cells and urinary adrenaline and noradrenaline levels. The elevated NK activity persisted for more than 7 days after the trip.
Li Q, Morimoto K, Kobayashi M, et al. J Biol Regul Homeost Agents, 2008. PMID 18394317
2008 / Randomized pilot trial
Thirty-six men and their partners were randomized to 11 dietary and cooking classes integrating mindfulness or to a wait-list control group. The intervention group demonstrated significant reductions in saturated fat consumption, increased intake of vegetable proteins, decreased intake of animal proteins including dairy, and increased quality of life. While no significant difference was found in the rate of PSA increase or log PSA slope between groups, the mean PSA doubling time was substantially longer in the intervention group compared with controls at 3-month follow-up.
Carmody J, Olendzki B, Reed G, et al. Urology, 2008. PMID 18400281
2008 / Uncontrolled pre-post trial (participants served as own controls)
Twenty-seven participants with oral intraepithelial neoplasia applied 0.5 g of a 10% freeze-dried black raspberry gel topically four times daily for 6 weeks, serving as their own internal controls. None of the 27 participants developed gel-associated toxicities. Results showed histologic regression in a subset of patients as well as a statistically significant reduction in loss of heterozygosity at tumor suppressor gene-associated loci.
Shumway BS, Kresty LA, Larsen PE, et al. Clin Cancer Res, 2008. PMID 18413833
2008 / Randomized controlled trial
In a randomized trial, 58 men at risk of or with low-grade prostate cancer consumed 40 g daily of isoflavone-rich soy protein, alcohol-washed soy protein, or milk protein for 6 months. Serum PSA and prostate tissue biomarkers did not change with isoflavone-rich soy protein, whereas Bax expression decreased with alcohol-washed soy. A significantly lower rate of prostate cancer was detected in the soy groups compared to the milk group (P = 0.01).
Hamilton-Reeves JM, Rebello SA, Thomas W, et al. Nutr Cancer, 2008. PMID 18444130
2008 / Open-label nonrandomized phase II trial
In an open-label, nonrandomized phase II trial, 20 patients with prostate-specific antigen recurrence after previous local therapy consumed soy milk containing 47 mg of isoflavones three times daily for 12 months. An estimated annual PSA increase of 56% before entry slowed to 20% during the trial (p = 0.05). Post-entry slope was significantly reduced in 6 patients, increased in 2 patients, and remained statistically unchanged in 12 patients.
Pendleton JM, Tan WW, Anai S, et al. BMC Cancer, 2008. PMID 18471323
2008 / Phase I non-randomized clinical trial
In a phase I dose-finding study, patients with advanced cancer received infusions of ascorbic acid ranging from 0.4 to 1.5 g/kg three times weekly. Toxicity and adverse events were minimal across all dose groups. However, no participant showed an objective anticancer response.
Hoffer LJ, Levine M, Assouline S, et al. Ann Oncol, 2008. PMID 18544557
2008 / Pre-post trial with baseline hemisected lesion biopsy
This study evaluated the effects of a 10% freeze-dried black raspberry gel applied topically (0.5 g four times daily for 6 weeks) to human oral intraepithelial neoplasia (IEN) lesions, using baseline hemisected biopsy samples as controls. Berry gel application uniformly suppressed genes linked to RNA processing, growth factor recycling, and apoptosis inhibition. Although most participants had posttreatment reductions in epithelial iNOS and COX-2 proteins, only the reductions in COX-2 reached statistical significance. In a subset of patients, berry gel application also reduced superficial connective tissue vascular densities and induced genes related to keratinocyte terminal differentiation.
Mallery SR, Zwick JC, Pei P, et al. Cancer Res, 2008. PMID 18559542
2008 / Pilot intervention study
A pilot study evaluated changes in prostate gene expression among men with low-risk prostate cancer undergoing active surveillance while participating in an intensive nutrition and lifestyle intervention. Significant improvements in weight, abdominal obesity, blood pressure, and lipid profiles were observed (all P < 0.05). Paired gene expression profiles from 30 participants revealed 48 up-regulated and 453 down-regulated transcripts after 3 months, with pathway analysis showing modulation of biological processes critical to tumorigenesis (P < 0.05).
Ornish D, Magbanua MJ, Weidner G, et al. Proc Natl Acad Sci U S A, 2008. PMID 18559852
2008 / Randomized controlled trial
A randomized trial followed 93 patients with early-stage prostate cancer on active surveillance for two years. Participants were assigned to usual care or a one-year program of a low-fat, plant-based diet, exercise, stress management, and support groups. By two years, 5% (2 of 43) of lifestyle participants had undergone conventional prostate cancer therapy versus 27% (13 of 49) of controls (P < .05). Untreated groups did not differ in PSA change or velocity.
Frattaroli J, Weidner G, Dnistrian AM, et al. Urology, 2008. PMID 18602144
2008 / Multicenter randomized, controlled, single-blinded clinical trial
A multicenter trial randomly assigned 1,277 peripheral arterial disease patients to iron reduction by phlebotomy (n = 636) or control (n = 641), followed for an average of 4.5 years. Risk of new visceral malignancy was lower in the iron reduction group compared to control (38 vs 60; HR = 0.65, 95% CI = 0.43 to 0.97; P = .036). Among patients who developed new cancers, those in the iron reduction group had lower cancer-specific mortality (HR = 0.39, 95% CI = 0.21 to 0.72; P = .003) and lower all-cause mortality (HR = 0.49, 95% CI = 0.29 to 0.83; P = .009).
Zacharski LR, Chow BK, Howes PS, et al. J Natl Cancer Inst, 2008. PMID 18612130
2008 / Phase II trial
Twenty-five patients with advanced pancreatic cancer received 8 g of oral curcumin daily until progression. Circulating conjugates peaked at 22 to 41 ng/mL, reflecting poor bioavailability. Two of 21 evaluable participants showed biological activity, including one individual with stable disease exceeding 18 months and another with a temporary 73% tumor reduction. Curcumin down-regulated peripheral mononuclear cell expression of NF-kappaB, COX-2, and pSTAT3 without causing toxicities.
Dhillon N, Aggarwal BB, Newman RA, et al. Clin Cancer Res, 2008. PMID 18628464
2008 / Pilot clinical trial
A pilot study evaluated 30 men with low-risk prostate cancer asked to adopt comprehensive lifestyle modifications for 3 months. In 24 participants with adequate samples, natural log-transformed telomerase activity was 2.00 at baseline and 2.22 after 3 months (p = 0.031). Increased telomerase activity correlated with lower LDL cholesterol (r = -0.36, p = 0.041) and less psychological distress (r = -0.35, p = 0.047).
Ornish D, Lin J, Daubenmier J, et al. Lancet Oncol, 2008. PMID 18799354
2008 / Phase I/II clinical trial
In this phase I/II trial, 20 patients with advanced malignancies receiving chemotherapy received a beta-(1,3)/(1,6) D-glucan formulation. Investigators monitored participants for tolerability and effects on blood cell production. The authors concluded that the fungal supplement was well-tolerated and may have a beneficial effect on hematopoiesis during chemotherapy.
Weitberg AB J Exp Clin Cancer Res, 2008. PMID 18803849
2008 / Comparative clinical trial
Researchers analyzed circulating markers from long-term human studies lasting 1 and 6 years. Severe calorie restriction with adequate nutrition did not change serum IGF-1 or the IGF-1 to IGFBP-3 ratio. In contrast, lowering protein intake from 1.67 to 0.95 g/kg/day for 3 weeks in six calorie-restricted volunteers reduced serum IGF-1 from 194 to 152 ng/mL.
Fontana L, Weiss EP, Villareal DT, et al. Aging Cell, 2008. PMID 18843793
2008 / Randomized controlled trial
Investigators randomly assigned 153 patients receiving remission induction therapy for acute myeloid leukemia in protected rooms to a cooked diet without raw produce (n=78) or a diet with fresh produce (n=75). Major infections developed in 29% of the cooked diet group and 35% of the raw diet group (P = .60). Time to major infection and survival were similar between groups, while fever of unknown origin occurred in 51% versus 36%.
Gardner A, Mattiuzzi G, Faderl S, et al. J Clin Oncol, 2008. PMID 18955453
2008 / Randomized controlled trial
In a randomized trial, patients who had colorectal adenomas removed and confirmed clean colon at 1 year were assigned to 1.5 g green tea extract daily (n=71) or no supplementation (n=65) for 12 months. Among the 125 patients completing follow-up colonoscopy, the incidence of metachronous adenomas was 15% (9 of 60) in the green tea extract group versus 31% (20 of 65) in controls (relative risk, 0.49; 95% CI, 0.24-0.99; P < 0.05). Relapsed adenoma size was also significantly smaller in the supplemented group (P < 0.001), with no serious adverse events reported.
Shimizu M, Fukutomi Y, Ninomiya M, et al. Cancer Epidemiol Biomarkers Prev, 2008. PMID 18990744
2008 / Multisite randomized controlled trial
Prostate cancer patients (n = 161) awaiting surgery were randomly assigned to a usual diet control, flaxseed supplementation (30 g/d), a low-fat diet (<20% energy), or a combined flaxseed and low-fat diet for an average of 30 days. Proliferation rates (Ki-67) were significantly lower (P < 0.002) in men in the flaxseed arms, with median Ki-67-positive ratios of 1.66 (flaxseed) and 1.50 (flaxseed + low-fat) compared to 3.23 (control) and 2.56 (low-fat). No significant differences between arms were observed for side effects, apoptosis, or most serologic endpoints, though low-fat diets significantly decreased serum cholesterol (P = 0.048).
Demark-Wahnefried W, Polascik TJ, George SL, et al. Cancer Epidemiol Biomarkers Prev, 2008. PMID 19064574
2008 / Randomized controlled primary prevention trial
In the Women's Health Initiative Dietary Modification trial, 48,835 postmenopausal women were randomized to a dietary modification intervention (aiming for 20% energy from fat, >=5 servings/d fruits/vegetables, and >=6 servings/d grains) or a comparison group. Over an average follow-up of 7.7 years, 570 incident cases of benign proliferative breast disease occurred in the intervention group and 793 in the comparison group. The hazard ratio comparing the intervention group to the comparison group was 1.09 (95% CI, 0.98-1.23). The intervention resulted in smaller than targeted changes in practice, and risk varied by baseline total vitamin D intake.
Rohan TE, Negassa A, Caan B, et al. Cancer Prev Res (Phila), 2008. PMID 19138971
2008 / Phase II randomized controlled trial
Forty-five men with clinically localized prostate cancer were randomized to receive 15, 30, or 45 mg of lycopene or no supplement from biopsy to prostatectomy (approximately 30 days). Plasma lycopene increased in all treatment groups, with the greatest increase in the 45 mg arm compared to controls, without producing toxicity. Serum free testosterone decreased with 30 mg lycopene, and total estradiol increased significantly with 30 mg and 45 mg from baseline to post-treatment, with no significant increases in serum PSA or tissue Ki-67. However, these changes were not statistically significant compared to the control group for the study's sample size and duration.
Kumar NB, Besterman-Dahan K, Kang L, et al. Clin Med Urol, 2008. PMID 20354574